Toledano-Pinedo M

References (12)

Title : Generation and validation of a novel multitarget small molecule in glioblastoma - Artetxe-Zurutuza_2025_Cell.Death.Dis_16_250
Author(s) : Artetxe-Zurutuza A , Iturrioz-Rodriguez N , Elizazu J , Toledano-Pinedo M , Porro-Perez A , De Goni I , Elua-Pinin A , Schaker-Hubner L , Azkargorta M , Elortza F , Iriepa I , Lopez-Munoz F , Moncho-Amor V , Hansen FK , Sampron N , Marco-Contelles JL , Matheu A
Ref : Cell Death Dis , 16 :250 , 2025
Abstract :
PubMedSearch : Artetxe-Zurutuza_2025_Cell.Death.Dis_16_250
PubMedID: 40185715

Title : Contilisant-Belinostat Hybrids: Polyfunctionalized Indole Derivatives as Multineurotarget Drugs for the Potential Treatment of Alzheimer's Disease - Schaker-Hubner_2025_ACS.Pharmacol.Transl.Sci_8_831
Author(s) : Schaker-Hubner L , Toledano-Pinedo M , Eimermacher S , Krasniqi V , Porro-Perez A , Tan K , Horn G , Stegen P , Elsinghorst PW , Wille T , Pietsch M , Gutschow M , Marco-Contelles J , Hansen FK
Ref : ACS Pharmacol Transl Sci , 8 :831 , 2025
Abstract :
PubMedSearch : Schaker-Hubner_2025_ACS.Pharmacol.Transl.Sci_8_831
PubMedID: 40109740

Title : Contilisant-Belinostat Hybrids: Polyfunctionalized Indole Derivatives as Multineurotarget Drugs for the Potential Treatment of Alzheimer's Disease - Schaker-Hubner_2025_ACS.Pharmacol.Transl.Sci_8_831
Author(s) : Schaker-Hubner L , Toledano-Pinedo M , Eimermacher S , Krasniqi V , Porro-Perez A , Tan K , Horn G , Stegen P , Elsinghorst PW , Wille T , Pietsch M , Gutschow M , Marco-Contelles J , Hansen FK
Ref : ACS Pharmacol Transl Sci , 8 :831 , 2025
Abstract :
PubMedSearch : Schaker-Hubner_2025_ACS.Pharmacol.Transl.Sci_8_831
PubMedID: 40109740

Title : Generation and Characterization of Novel Contilisant+Tubastatin a Multitarget Small Molecules Against Glioblastoma - de Goni_2025_Pharmaceutics_17_
Author(s) : De Goni I , Artetxe-Zurutuza A , Elizazu J , Garcia-Garcia de Garayo R , Vergara-Arce J , Azkargorta M , Toledano-Pinedo M , Porro-Perez A , Elortza F , Marco-Contelles JL , Sampron N , Iturrioz-Rodriguez N , Matheu A
Ref : Pharmaceutics , 17 : , 2025
Abstract :
PubMedSearch : de Goni_2025_Pharmaceutics_17_
PubMedID: 41471109

Title : Contilisant-Belinostat Hybrids: Polyfunctionalized Indole Derivatives as Multineurotarget Drugs for the Potential Treatment of Alzheimer's Disease - Schaker-Hubner_2025_ACS.Pharmacol.Transl.Sci_8_831
Author(s) : Schaker-Hubner L , Toledano-Pinedo M , Eimermacher S , Krasniqi V , Porro-Perez A , Tan K , Horn G , Stegen P , Elsinghorst PW , Wille T , Pietsch M , Gutschow M , Marco-Contelles J , Hansen FK
Ref : ACS Pharmacol Transl Sci , 8 :831 , 2025
Abstract :
PubMedSearch : Schaker-Hubner_2025_ACS.Pharmacol.Transl.Sci_8_831
PubMedID: 40109740

Title : Generation and validation of a novel multitarget small molecule in glioblastoma - Artetxe-Zurutuza_2025_Cell.Death.Dis_16_250
Author(s) : Artetxe-Zurutuza A , Iturrioz-Rodriguez N , Elizazu J , Toledano-Pinedo M , Porro-Perez A , De Goni I , Elua-Pinin A , Schaker-Hubner L , Azkargorta M , Elortza F , Iriepa I , Lopez-Munoz F , Moncho-Amor V , Hansen FK , Sampron N , Marco-Contelles JL , Matheu A
Ref : Cell Death Dis , 16 :250 , 2025
Abstract :
PubMedSearch : Artetxe-Zurutuza_2025_Cell.Death.Dis_16_250
PubMedID: 40185715

Title : Generation and Characterization of Novel Contilisant+Tubastatin a Multitarget Small Molecules Against Glioblastoma - de Goni_2025_Pharmaceutics_17_
Author(s) : De Goni I , Artetxe-Zurutuza A , Elizazu J , Garcia-Garcia de Garayo R , Vergara-Arce J , Azkargorta M , Toledano-Pinedo M , Porro-Perez A , Elortza F , Marco-Contelles JL , Sampron N , Iturrioz-Rodriguez N , Matheu A
Ref : Pharmaceutics , 17 : , 2025
Abstract :
PubMedSearch : de Goni_2025_Pharmaceutics_17_
PubMedID: 41471109

Title : Generation and Characterization of Novel Contilisant+Tubastatin a Multitarget Small Molecules Against Glioblastoma - de Goni_2025_Pharmaceutics_17_
Author(s) : De Goni I , Artetxe-Zurutuza A , Elizazu J , Garcia-Garcia de Garayo R , Vergara-Arce J , Azkargorta M , Toledano-Pinedo M , Porro-Perez A , Elortza F , Marco-Contelles JL , Sampron N , Iturrioz-Rodriguez N , Matheu A
Ref : Pharmaceutics , 17 : , 2025
Abstract :
PubMedSearch : de Goni_2025_Pharmaceutics_17_
PubMedID: 41471109

Title : Generation and validation of a novel multitarget small molecule in glioblastoma - Artetxe-Zurutuza_2025_Cell.Death.Dis_16_250
Author(s) : Artetxe-Zurutuza A , Iturrioz-Rodriguez N , Elizazu J , Toledano-Pinedo M , Porro-Perez A , De Goni I , Elua-Pinin A , Schaker-Hubner L , Azkargorta M , Elortza F , Iriepa I , Lopez-Munoz F , Moncho-Amor V , Hansen FK , Sampron N , Marco-Contelles JL , Matheu A
Ref : Cell Death Dis , 16 :250 , 2025
Abstract :
PubMedSearch : Artetxe-Zurutuza_2025_Cell.Death.Dis_16_250
PubMedID: 40185715

Title : Contilistat, a new polyfunctionalized histone deacetylase inhibitor, showing potential capacity to inhibit cholinesterase\/monoamine oxidase enzymes, and modulate histamine 3, sigma 1, 5-HT6 and dopamine 3 receptors for the treatment of cancer and neurodegenerative diseases - Diez-Iriepa_2023_Chemrxiv__
Author(s) : Diez-Iriepa D , Toledano-Pinedo M , Porro A , Almendros P , Rodriguez-Fernandez, MM , Samadi A , Iriepa I , Lopez-Munoz F , Artetxe-Zurutuza A , Matheu A , Marco-Contelles J
Ref : Chemrxiv , : , 2023
Abstract :
PubMedSearch : Diez-Iriepa_2023_Chemrxiv__
PubMedID:

Title : Contilistat, a new polyfunctionalized histone deacetylase inhibitor, showing potential capacity to inhibit cholinesterase\/monoamine oxidase enzymes, and modulate histamine 3, sigma 1, 5-HT6 and dopamine 3 receptors for the treatment of cancer and neurodegenerative diseases - Diez-Iriepa_2023_Chemrxiv__
Author(s) : Diez-Iriepa D , Toledano-Pinedo M , Porro A , Almendros P , Rodriguez-Fernandez, MM , Samadi A , Iriepa I , Lopez-Munoz F , Artetxe-Zurutuza A , Matheu A , Marco-Contelles J
Ref : Chemrxiv , : , 2023
Abstract :
PubMedSearch : Diez-Iriepa_2023_Chemrxiv__
PubMedID:

Title : Contilistat, a new polyfunctionalized histone deacetylase inhibitor, showing potential capacity to inhibit cholinesterase\/monoamine oxidase enzymes, and modulate histamine 3, sigma 1, 5-HT6 and dopamine 3 receptors for the treatment of cancer and neurodegenerative diseases - Diez-Iriepa_2023_Chemrxiv__
Author(s) : Diez-Iriepa D , Toledano-Pinedo M , Porro A , Almendros P , Rodriguez-Fernandez, MM , Samadi A , Iriepa I , Lopez-Munoz F , Artetxe-Zurutuza A , Matheu A , Marco-Contelles J
Ref : Chemrxiv , : , 2023
Abstract :
PubMedSearch : Diez-Iriepa_2023_Chemrxiv__
PubMedID: